Henry Schein Inc
NASDAQ:HSIC
Gross Margin
Henry Schein Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.1B USD |
32%
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
88.2B USD |
4%
|
|
| US |
|
Cencora Inc
NYSE:COR
|
55.8B USD |
3%
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
55.5B USD |
3%
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
33.5B USD |
3%
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
34.7B AUD |
7%
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
65.2B CNY |
33%
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
30%
|
|
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
8.2B USD |
13%
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
57.4B HKD |
8%
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
51.6B CNY |
11%
|
Henry Schein Inc
Glance View
In the evolving landscape of healthcare distribution, Henry Schein Inc. has carved out a robust niche, establishing itself as a pivotal player in delivering essential products and services. Founded in 1932, the company initially responded to the growing need for medical supplies with a simple commitment to customer service and innovation. Today, the company profiles as the world’s largest provider of healthcare products and services to office-based dental and medical practitioners, alongside its veterinary arm. It services a global footprint, channeling its efforts into dental, medical, and animal health sectors. The company's sprawling network deploys a vast array of products—from consumables to equipment—to a multitude of healthcare professionals, accentuating its integral role in the clinical toolkit. Henry Schein's revenue engine thrives on a meticulously crafted business model that combines the breadth of a comprehensive catalog with targeted value-added services. Its diverse product offerings span dental implants, vaccines, pharmaceuticals, and surgical supplies, delivered through direct sales and sophisticated logistical frameworks. Moreover, Henry Schein supplements its product lines with a suite of services, including practice management solutions and e-commerce platforms, that streamline operations for practitioners and enhance client loyalty. Strategic partnerships and acquisitions show the company's commitment to innovation, driving efficiencies and expanding its reach. This continuous adaptation keeps Henry Schein at the forefront of healthcare trends, ensuring steady streams of income flowing from both longstanding relationships and new market opportunities.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Henry Schein Inc's most recent financial statements, the company has Gross Margin of 31.7%.
You don't have any saved screeners yet